Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 2 boards, counting each seat separately. Longest: Q32 Bio Inc., 3 years.
Q32 Bio Inc.
Director
CervoMed Inc.
Director
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
CervoMed Inc. June 23, 202599.1%
-
CervoMed Inc. June 11, 202499.8%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 4, 2026 | Alnylam Pharmaceuticals Inc. | Open-market sale | −114 | $319.03 | $36,369 |
| Mar 4, 2026 | Alnylam Pharmaceuticals Inc. | Open-market sale | −109 | $320.01 | $34,881 |
| Mar 4, 2026 | Alnylam Pharmaceuticals Inc. | Open-market sale | −230 | $320.81 | $73,786 |
| Mar 4, 2026 | Alnylam Pharmaceuticals Inc. | Open-market sale | −309 | $321.82 | $99,442 |
| Mar 4, 2026 | Alnylam Pharmaceuticals Inc. | Open-market sale | −374 | $323.01 | $120,806 |
| Mar 4, 2026 | Alnylam Pharmaceuticals Inc. | Open-market sale | −818 | $323.84 | $264,901 |
| Mar 4, 2026 | Alnylam Pharmaceuticals Inc. | Open-market sale | −291 | $324.88 | $94,540 |
| Mar 4, 2026 | Alnylam Pharmaceuticals Inc. | Open-market sale | −223 | $325.67 | $72,624 |
| Mar 2, 2026 | Alnylam Pharmaceuticals Inc. | Grant or award | +4,769 | — | — |
| Mar 2, 2026 | Alnylam Pharmaceuticals Inc. | Open-market sale | −65 | $323.62 | $21,035 |
| Mar 2, 2026 | Alnylam Pharmaceuticals Inc. | Open-market sale | −124 | $324.65 | $40,257 |
| Mar 2, 2026 | Alnylam Pharmaceuticals Inc. | Open-market sale | −356 | $325.63 | $115,924 |
| Mar 2, 2026 | Alnylam Pharmaceuticals Inc. | Open-market sale | −541 | $326.81 | $176,804 |
| Mar 2, 2026 | Alnylam Pharmaceuticals Inc. | Open-market sale | −454 | $327.67 | $148,762 |
| Mar 2, 2026 | Alnylam Pharmaceuticals Inc. | Open-market sale | −138 | $328.71 | $45,362 |
Questions about Jeffrey Poulton V
What boards is Jeffrey Poulton V on?
Jeffrey Poulton V sits on the boards of CervoMed Inc. and Q32 Bio Inc.
How long has Jeffrey Poulton V served on boards?
Our records show at least 7 years of board service across 2 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.